IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 62 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,539,000 | -28.3% | 3,438,529 | -0.1% | 0.02% | -38.5% |
| Q1 2018 | $6,334,000 | -12.8% | 3,442,364 | -0.0% | 0.04% | -30.4% |
| Q4 2017 | $7,263,000 | +3.0% | 3,442,519 | +8.9% | 0.06% | -13.8% |
| Q3 2017 | $7,052,000 | +30.2% | 3,162,261 | +0.4% | 0.06% | +4.8% |
| Q2 2017 | $5,417,000 | -30.4% | 3,149,431 | -0.1% | 0.06% | -36.1% |
| Q1 2017 | $7,787,000 | +64.7% | 3,152,658 | +0.0% | 0.10% | +98.0% |
| Q4 2016 | $4,729,000 | -41.3% | 3,152,583 | +0.1% | 0.05% | -47.3% |
| Q3 2016 | $8,061,000 | +67.1% | 3,148,916 | 0.0% | 0.09% | +3.3% |
| Q2 2016 | $4,825,000 | -22.6% | 3,148,916 | 0.0% | 0.09% | -14.3% |
| Q1 2016 | $6,235,000 | -35.9% | 3,148,916 | 0.0% | 0.10% | -35.2% |
| Q4 2015 | $9,730,000 | -7.8% | 3,148,916 | 0.0% | 0.16% | -26.4% |
| Q3 2015 | $10,549,000 | -9.7% | 3,148,916 | 0.0% | 0.22% | +39.2% |
| Q2 2015 | $11,682,000 | 0.0% | 3,148,916 | 0.0% | 0.16% | -1.9% |
| Q1 2015 | $11,682,000 | -15.9% | 3,148,916 | 0.0% | 0.16% | -16.1% |
| Q4 2014 | $13,887,000 | +92.6% | 3,148,916 | 0.0% | 0.19% | +73.0% |
| Q3 2014 | $7,211,000 | -21.0% | 3,148,916 | 0.0% | 0.11% | +0.9% |
| Q2 2014 | $9,132,000 | -28.9% | 3,148,916 | -0.0% | 0.11% | -34.1% |
| Q1 2014 | $12,849,000 | -11.9% | 3,149,116 | -0.0% | 0.17% | +33.6% |
| Q4 2013 | $14,583,000 | +166.2% | 3,149,816 | +0.0% | 0.12% | +111.9% |
| Q3 2013 | $5,479,000 | +165.6% | 3,148,916 | 0.0% | 0.06% | +103.4% |
| Q2 2013 | $2,063,000 | – | 3,148,916 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|